277 related articles for article (PubMed ID: 31391276)
1. Novel Multiplex Immunoassays for Quantification of IgG against Group B
Buffi G; Galletti B; Stella M; Proietti D; Balducci E; Romano MR; Mori E; Fabbrini M; Giuliani MM; Berti F; Margarit I
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391276
[TBL] [Abstract][Full Text] [Related]
2. The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera.
Fabbrini M; Rigat F; Rinaudo CD; Passalaqua I; Khacheh S; Creti R; Baldassarri L; Carboni F; Anderloni G; Rosini R; Maione D; Grandi G; Telford JL; Margarit I
Clin Infect Dis; 2016 Sep; 63(6):746-753. PubMed ID: 27402816
[TBL] [Abstract][Full Text] [Related]
3. A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B streptococcus type-specific antibodies in humans.
Basham LE; Pavliak V; Li X; Hawwari A; Kotloff KL; Edelman R; Fattom A
Vaccine; 1996 Apr; 14(5):439-45. PubMed ID: 8735557
[TBL] [Abstract][Full Text] [Related]
4. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
[TBL] [Abstract][Full Text] [Related]
5. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
[TBL] [Abstract][Full Text] [Related]
6. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Kasper DL; Paoletti LC; Wessels MR; Guttormsen HK; Carey VJ; Jennings HJ; Baker CJ
J Clin Invest; 1996 Nov; 98(10):2308-14. PubMed ID: 8941648
[TBL] [Abstract][Full Text] [Related]
7. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.
Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Carey VJ; Hickman ME; Kasper DL
J Infect Dis; 2000 Oct; 182(4):1129-38. PubMed ID: 10979909
[TBL] [Abstract][Full Text] [Related]
8. Immune Responses to Invasive Group B Streptococcal Disease in Adults.
Edwards MS; Rench MA; Rinaudo CD; Fabbrini M; Tuscano G; Buffi G; Bartolini E; Bonacci S; Baker CJ; Margarit I
Emerg Infect Dis; 2016 Nov; 22(11):1877-1883. PubMed ID: 27767008
[TBL] [Abstract][Full Text] [Related]
9. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of 13-plex Luminex-Based Assay for Measuring Human Serum Antibodies to
Pavliakova D; Giardina PC; Moghazeh S; Sebastian S; Koster M; Pavliak V; McKeen A; French R; Jansen KU; Pride M
mSphere; 2018 Aug; 3(4):. PubMed ID: 30089645
[TBL] [Abstract][Full Text] [Related]
12. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
[TBL] [Abstract][Full Text] [Related]
13. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Validated Luminex-Based Multiplex Immunoassay for Measuring Immunoglobulin G Antibodies in Serum to Pneumococcal Capsular Polysaccharides.
Tan CY; Immermann FW; Sebastian S; Pride MW; Pavliakova D; Belanger KA; Watson W; Scott DA; Sidhu M; Jansen KU; Giardina PC
mSphere; 2018 Aug; 3(4):. PubMed ID: 30089644
[TBL] [Abstract][Full Text] [Related]
15. Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.
Bhushan R; Anthony BF; Frasch CE
Infect Immun; 1998 Dec; 66(12):5848-53. PubMed ID: 9826364
[TBL] [Abstract][Full Text] [Related]
16. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
Guttormsen HK; Baker CJ; Nahm MH; Paoletti LC; Zughaier SM; Edwards MS; Kasper DL
Infect Immun; 2002 Apr; 70(4):1724-38. PubMed ID: 11895934
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
Davies HD; Adair C; McGeer A; Ma D; Robertson S; Mucenski M; Kowalsky L; Tyrell G; Baker CJ
J Infect Dis; 2001 Aug; 184(3):285-91. PubMed ID: 11443553
[TBL] [Abstract][Full Text] [Related]
18. Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.
Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Vaccine; 2000 Nov; 19(7-8):850-61. PubMed ID: 11115709
[TBL] [Abstract][Full Text] [Related]
19. Multilaboratory Comparison of Pneumococcal Multiplex Immunoassays Used in Immunosurveillance of Streptococcus pneumoniae across Europe.
Meek B; Ekström N; Kantsø B; Almond R; Findlow J; Gritzfeld JF; Sværke Jørgensen C; Ljungberg K; Atterfelt F; Batstra MR; Andeweg K; de Jong BAW; Prince HE; Lapé-Nixon M; Gageldonk PGM; Tcherniaeva I; Aaberge I; Herstad TK; Melin M; Rijkers GT; Berbers GA
mSphere; 2019 Nov; 4(6):. PubMed ID: 31776237
[TBL] [Abstract][Full Text] [Related]
20. A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.
Buurman ET; Timofeyeva Y; Gu J; Kim JH; Kodali S; Liu Y; Mininni T; Moghazeh S; Pavliakova D; Singer C; Singh S; Handke LD; Lotvin J; Prasad AK; Scully IL; Donald RGK; Jansen KU; Anderson AS
J Infect Dis; 2019 Jun; 220(1):105-115. PubMed ID: 30778554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
